COA vs GC-MS for Essential Oil Buyers

Two documents, two different jobs

A COA is normally the concise release summary for a defined lot against an agreed specification. It tells the buyer which tests were performed, the acceptance limits and the reported results. A GC-MS report presents a more detailed volatile constituent profile. The two documents overlap around identity and composition, but they are not interchangeable and neither should be reviewed without the product specification.

Think of the specification as the rulebook, the COA as the batch scorecard and GC-MS as a closer view of volatile composition. The correct combination depends on the oil and application. Carrier oils, for example, may rely more heavily on fatty-acid profile, acid value and peroxide value than on an essential-oil-style GC-MS report. The document request should follow the material rather than a fixed template.

What to check on a COA

First confirm identity: product name, botanical name where shown, lot number and relevant dates should match the offer and sample. Then compare every reported result with the agreed limits. Appearance and aroma may be descriptive, while density, refractive index, optical rotation or other parameters provide measurable controls where relevant. Note any missing test that your approved specification requires.

A result marked compliant is not enough if the underlying value or limit is absent from a decision your quality system needs to review. Ask what method was used when method differences could affect comparison. Confirm who authorized release and whether the COA is an illustrative sample or tied to the actual commercial lot. Keep the approved COA with the purchase and complaint records.

What to check on a GC-MS report

Verify that the report identifies the same product and lot, then review the named constituents and their relative distribution against your acceptance criteria or approved reference. Pay attention to the botanical species, plant part, extraction route and any declared chemotype because those details shape the expected profile. A long constituent list does not automatically mean the material is authentic or appropriate.

Use qualified technical review where composition decisions affect formulation or claims. Natural oils vary with genetics, climate, harvest and processing, so the goal is not an impossible identical chromatogram. The goal is an explainable profile that meets the agreed range and application need. Unusual peaks, missing expected constituents or inconsistent lot information deserve clarification before approval.

Resolve apparent conflicts systematically

If the COA says a lot passes but the GC-MS appears inconsistent with your standard, pause the release decision. Confirm that both reports refer to the same lot and that the comparison uses compatible methods and naming conventions. Ask the supplier to explain the result and, if needed, provide raw or supplementary information through the agreed technical channel.

Do not solve conflicts by choosing the document with the preferred answer. Record the discrepancy, risk, investigation and disposition. The offered lot may still be acceptable after an explained method or naming difference, or it may require replacement. A defined deviation process protects both parties and creates a clearer basis for future batches.

Create a proportionate review workflow

At supplier qualification, review example formats and confirm testing capability. At sample review, obtain documents tied to the sample where available and test the material in its intended formulation. Before commercial release, check the actual lot against the approved specification. Decide which changes require notification or reapproval, such as a different origin, chemotype, extraction route or meaningful composition shift.

Keep the workflow proportionate to the product and risk. More paperwork is not automatically better evidence. A smaller set of current, consistent, lot-linked documents is more useful than many unrelated certificates. When requesting a quote, tell the supplier exactly which COA parameters and GC-MS expectations matter so the proposed batch and documentation route can be assessed early.

Document the approval decision, not just the reports

A COA and GC-MS report become useful only when the buyer records how they were evaluated. Keep a review note that identifies the product and lot, approved specification, report dates, sample reference, reviewer and conclusion. If a constituent or physical result sits near an acceptance limit, note whether additional monitoring is needed for the next lot. This creates continuity when personnel change and reduces repeated interpretation.

Connect the analytical decision to finished-formula observations. An oil can meet constituent limits yet produce a sensory or stability outcome that is unsuitable for a particular product. Conversely, a natural profile difference may be technically acceptable when it remains within the agreed standard and performs as required. Procurement should not make this judgment alone; quality and formulation owners need a defined role in the decision.

Agree escalation steps before a discrepancy occurs. The first response may be a report identity check, followed by method clarification, retained-sample review or additional testing where justified. Record who bears timing and commercial consequences under the applicable agreement. A transparent process protects supply continuity without lowering the acceptance standard and avoids making a rushed shipment decision through disconnected email messages.

• Record lot and sample identity
• Compare against the approved specification
• Capture technical reviewer and conclusion
• Define deviation escalation

Confirm timing before shipment

Ask when the final COA and GC-MS files become available and whether shipment waits for written buyer approval. Name the person or function authorized to release the lot. This prevents a correct analytical review from becoming a late logistics problem and ensures that commercial urgency cannot silently bypass the agreed technical gate.